RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
WOFDX
Price
$57.77
Change
-$1.03 (-1.75%)
Updated
Jun 13 closing price
Net Assets
1.8B
Interact to see
Advertisement

RGEBX vs WOFDX

Header iconRGEBX vs WOFDX Comparison
Open Charts RGEBX vs WOFDXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
Allspring Opportunity Admin
Price$57.77
Change-$1.03 (-1.75%)
VolumeN/A
Net Assets1.8B
RGEBX vs WOFDX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGEBX vs. WOFDX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and WOFDX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. WOFDX (1.8B). RGEBX (0.00) and WOFDX (0.00) have matching dividends . RGEBX was incepted earlier than WOFDX: RGEBX (11 years) vs WOFDX (23 years). WOFDX (1.12) and RGEBX (1.09) have similar cost to investors . RGEBX is a more actively managed with annual turnover of: 25.00 vs. WOFDX (20.00). RGEBX has a lower initial minimum investment than WOFDX: RGEBX (250) vs WOFDX (1000000). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. WOFDX (-1.18). RGEBX return over 5 years is better than : 45.42 vs. WOFDX (26.88).
RGEBXWOFDXRGEBX / WOFDX
Total Expense Ratio1.091.00109%
Annual Report Gross Expense Ratio1.091.1297%
Fund Existence11 years23 years-
Gain YTD4.829-2.448-197%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets306B1.8B16,962%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.68-1.18-651%
Returns for 3 years51.0122.06231%
Returns for 5 years45.4226.88169%
Returns for 10 years65.8714.10467%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVEE22.920.14
+0.61%
NV5 Global Inc
MDGL295.57-1.64
-0.55%
Madrigal Pharmaceuticals
TPVG7.21-0.16
-2.17%
TRIPLEPOINT VENTURE GROWTH BDC Corp
LRCX89.52-2.14
-2.33%
Lam Research Corp
PRLD0.96-0.08
-7.68%
Prelude Therapeutics